PHILADELPHIA, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced its sponsorship of the Conference on “Diagnosis, Treatments and New Developments in ME and CFS” (“Myalgic Encephalomyelitis” and “Chronic Fatigue Syndrome”) which will be held on November 20th beginning at 11 AM (EST) at the New York Academy of Medicine, 1215 Fifth Avenue/103rd Street, New York, NY. The program is the second symposium by The ME and CFS Center at Mount Sinai Medical Center in New York, which is headed by CFS expert, Dr. Derek Enlander.
Help employers find you! Check out all the jobs and post your resume.